Repeal of Contentious Medical Device Tax Passes in House

As expected, the “Protect Medical Innovation At” (H.R. 160) passed in the U.S. House of Representatives earlier this month. The bill would effectively repeal the medical device excise tax enacted in 2013 as part of the Patient Protection and Affordable Care Act (ACA). Proponents of the repeal contend the added cost has depressed research and development (R&D) within the device industry. Kalorama Information regularly assesses industry R&D trends by tracking related expenditures of the most repre...


Hematology Will Play - Roche Moves Closer to High-Growth Core Lab Market Segment

Hematology Will Play - Roche Moves Closer to High-Growth Core Lab Market Segment

This blog updates developments in the markets for hematology and core lab diagnostics comprehensively covered in the Kalorama Information reports The World Market for Hematology and The Worldwide Market for In Vitro Diagnostic Tests, 9 th Edition.

True to its name, Roche’s Bloodhound technology is on the trail of a conspicuously high-growth market segment in hematology testing. Digital cell imaging and morphology analysis is a significant addition to conventional core lab hematology capabiliti...


With Next-Generation Sequencing, MDx Catches Up to Antimicrobial Resistance

With Next-Generation Sequencing, MDx Catches Up to Antimicrobial Resistance

Market information and other trends regarding next-generation sequencing and healthcare-acquired infections are available through Kalorama Information reports Next Generation Sequencing (NGS) Markets 2015 and Healthcare Associated Infection (HAI) Control Markets.

A powerful tool for the development of now ubiquitous molecular infectious disease assays, sequencing is also capable of directly impacting clinical decision-making and disease control as an in vitro diagnostic (IVD). Next generation ...


CVS to Gain 80 Retail Clinic Locations In Target Deal

CVS to Gain 80 Retail Clinic Locations In Target Deal

In addition to boosting its core drugstore business, CVS is about to cement its position as the largest retail clinic operator. CVS said it will gain 80 retail health clinic locations as part of a proposed deal with Target announced June 15th. This might be an underreported detail in a deal of this size, but we think it’s significant. CVS has made it a goal to expand its provision of health services and to benefit from the indirect revenue clinics provide to the pharmacy operation. They now get ...


Large Market for Point of Care Testing

Large Market for Point of Care Testing

The market for point of care diagnostics reached $17 billion, in 2014, according to our most recent report on the topic. Expect solid competitive activity, but tempered growth due to pricing strategies that continue to discount the cost of point of care (or POC) diagnostic testing in some segments and higher cost in other segments of testing.

For information on the report, see http://www.kaloramainformation.com/Point-Care-POC-9030928/


The menu for point-of-care testing continues to expand. ...


Ariosa Matches Sequenom-Illumina with NIPT LDT Licensing Move

Following the agreement between Sequenom and Illumina earlier this year allowing the latter to license pooled non-invasive prenatal testing (NIPT) IP to third-party labs worldwide, Roche Diagnostics’ Ariosa Diagnostics announced this week that it would grant licenses to labs for its own technology relating to NIPT. The three major players in prenatal testing operate their own labs to perform NIPT services on sent-out samples, but have encouraged outside labs to adopt their technologies in order ...


Biopharmaceutical Boom Drives Cell Culture Market Growth

Biopharmaceutical Boom Drives Cell Culture Market Growth

Biopharmaceuticals have become a primary growth driver for not only pharmaceutical companies, but also upstream bioprocessing product suppliers. The production of vaccines, hormones, blood factors, thrombolytics, interferons, monoclonal antibodies and therapeutic enzymes requires cell culturing and the voluminous supply of culture media, sera, and reagents. The market for cell cultures is expected to grow rapidly alongside biopharmaceuticals and with significant evolution in culture technology. ...


Rising Positivity Rates in Employment Screening Underscore Continued Market Growth for Drugs of Abuse Tests

Rising Positivity Rates in Employment Screening Underscore Continued Market Growth for Drugs of Abuse Tests

Quest Diagnostics recently announced the results of over 10 million drug tests it performed in the United States in 2014, including the continued reversal of a decades’ long trend of falling positivity rates for illicit substances in U.S. employment testing. Quest’s results from drug testing reinforce Kalorama Information’s expectation of a reinvigorated global market, led by the United States, for drugs of abuse test kits and reagents. In Drugs of Abuse Testing and Technologies Market , Kaloram...